when was tirzepatide approved for Weight Loss Zepbound (tirzepatide) FDA Approval History

I wont get my meds anywhere else

A network meta-analysis of 19 randomized controlled trials involving more than 13,000 participants found that tirzepatide had a higher incidence of injection site reactions compared to semaglutide

GLP-1s are generally considered safe when used as prescribed

Most current studies focus on preclinical models or specific populations, such as those with type 2 diabetes, which may not be representative of the broader population of women suffering from endometriosis

On the other hand, insulin secretion was primarily stimulated by high glucose and amplificated by Gs-coupled receptors such ss GLP-1-stimulated GLP-1 receptor in GLP-1R-MIN-6 cells

| Weight loss: what the evidence shows | Side effects and tolerability | Dosing and practical differences | Cost and access in the UK | Who might prefer each option